kt 5823 has been researched along with verapamil in 1 studies
Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
317 | 0 | 59 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Spector, AA; Stoll, LL | 1 |
1 other study(ies) available for kt 5823 and verapamil
Article | Year |
---|---|
Lysophosphatidylcholine causes cGMP-dependent verapamil-sensitive Ca2+ influx in vascular smooth muscle cells.
Topics: Alkaloids; Animals; Aorta, Thoracic; Biological Transport; Calcium; Carbazoles; Cells, Cultured; Cyclic GMP; Fura-2; Indoles; Kinetics; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Protein Kinase Inhibitors; Spectrometry, Fluorescence; Swine; Verapamil | 1993 |